Unique ID issued by UMIN | UMIN000011390 |
---|---|
Receipt number | R000013340 |
Scientific Title | A prospective feasibility study of reduced-port laparoscopic distal gastrectomy for clinical stage I gastric cancer |
Date of disclosure of the study information | 2013/10/01 |
Last modified on | 2014/12/19 15:49:15 |
A prospective feasibility study of reduced-port laparoscopic distal gastrectomy for clinical stage I gastric cancer
A prospective feasibility study of reduced-port laparoscopic distal gastrectomy for clinical stage I gastric cancer
A prospective feasibility study of reduced-port laparoscopic distal gastrectomy for clinical stage I gastric cancer
A prospective feasibility study of reduced-port laparoscopic distal gastrectomy for clinical stage I gastric cancer
Japan |
gastric cancer
Gastrointestinal surgery |
Malignancy
NO
To demonstrate the non-inferiority of incidence of postoperative complication of reduced-port laparoscopic distal gastrectomy with lymph node dissection compared with conventional laparoscopic distal gastrectomy for clinical stage IA or IB gastric cancer.
Safety
incidence of postoperative complication
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Maneuver |
Reduced-port laparoscopic gastrectomy
20 | years-old | <= |
80 | years-old | >= |
Male and Female
1) Histologically proven gastric adenocarcinoma.
2) cStage IA(T1N0) or IB(T1N1, T2[MP]N0).
3) Tumor located in the middle or lower third of the stomach, and curative resection is expected to be achivable by distal gastrectomy.
4) Aged 20 to 80 years.
5) Body mass index less than 30.
6) PS (ECOG) of 0 or 1.
7) No history of upper abdominal surgery.
8) No prior treatment of chemotherapy or radiation therapy against any other malignancies.
1) Synchronous or metachronous (within 5 years) malignancies other than carcinoma in situ.
2) Infectious disease with systemic therapy indicated.
3) Body temperature of 38 or more degrees Celsius.
4) Women during pregnancy or breast-feeding.
5) Severe mental disease.
6) Continuous systemic steroid therapy.
7) Unstable angina pectoris, or history of myocardial infarction within six months.
8) Uncontrollable hypertension.
9) Uncontrollable diabetes millutus.
10) Severe respiratory disease requiring continuous oxygen therapy.
55
1st name | |
Middle name | |
Last name | Yasuhiro Kodera |
Graduate School of Medicine, Nagoya University
Department of Gastroenterological Surgery
65, Tsurumai-cho, Showa-ku, Nagoya, Aiti 466-8550, JAPAN
052-744-2250
ykodera@med.nagoya-u.ac.jp
1st name | |
Middle name | |
Last name | Chie TANAKA |
Graduate School of Medicine, Nagoya University
Department of Gastroenterological Surgery
65, Tsurumai-cho, Showa-ku, Nagoya, Aiti 466-8550, JAPAN
052-744-2250
chtanaka@med.nagoya-u.ac.jp
Department of Gastroenterological Surgery, Graduate School of Medicine, Nagoya University
none
Other
NO
2013 | Year | 10 | Month | 01 | Day |
Unpublished
Open public recruiting
2013 | Year | 11 | Month | 01 | Day |
2013 | Year | 11 | Month | 01 | Day |
2013 | Year | 08 | Month | 06 | Day |
2014 | Year | 12 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013340
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |